retatrutide effects clinical trials Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Retatrutide clinical trial done! Now

Learn more about Elite's GLP-1 Membership and how it is unique and supportive to each clients' baseline and goals.

Appendicitis is a common medical condition characterized by the inflammation of the appendix, a small pouch attached to the large intestine

Lillys legal offensive against compounders of its popular weight loss drugs hits another snag in court.

Discover the truth about GLP-1 receptor agonists, their Gila monster origins, modern manufacturing methods, and UK safety regulations for diabetes and weight management.

Our deep and diverse obesity clinical pipeline is built to attempt to address critical gaps in care and meet patients where they are with optionality

The @LaskerFDN 2024 Clinical Medical Research Award goes to GLP-1 scientists: Joel Habener, Svetlana Mojsov and @lotte_bjerre Perspective @NEJM by @DanielJDrucker